ALX ONCOLOGY HOLDINGS INC (ALXO) Return on equity 2020–2022
ALX ONCOLOGY HOLDINGS INC (ALXO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-46.9%FY2022 · since FY2020: -10.6% → -46.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -46.9% | -23.9 pp |
| FY2021 | -23.0% | -12.3 pp |
| FY2020 | -10.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More ALXO financial trends
ALXO RevenueALXO Net incomeALXO Net marginALXO Gross profitALXO Gross marginALXO Operating incomeALXO Operating marginALXO Operating cash flowALXO Free cash flowALXO Capital expendituresALXO Stock buybacksALXO Dividends paidALXO Total assetsALXO Total liabilitiesALXO Shareholders’ equityALXO overview →